Stock listing
Outlook Therapeutics, Inc.
Selected listing: OTLK · NASDAQ · USD · US
Outlook Therapeutics, Inc. (NASDAQ:OTLK), Health Technology. Latest release Oct 6, 2026: Outlook Therapeutics Highlights What the Appointment of New CFO Kevin…
- Ticker
- NASDAQ:OTLK
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. is a public company traded under the ticker OTLK in the American market. Outlook Therapeutics focuses on developing innovative therapies to address unmet medical needs.
Latest news from Outlook Therapeutics, Inc.
Outlook Therapeutics Highlights What the Appointment of New CFO Kevin Lundquist Means for the Company’s Next Chapter in Virtual Investor Discussion
October 6, 2026
Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)
October 1, 2026
Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)
September 30, 2026
Outlook Therapeutics Fireside Chat from H.C. Wainwright Conference Now Available On-Demand
September 11, 2026
Outlook Therapeutics CEO, Bob Jahr, Discusses FDA Approval and Commercial Opportunity for LYTENAVA™ in Virtual Investor CEO Connect Segment
September 10, 2026
Events
Research Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. company profile
View the public company page for Outlook Therapeutics, Inc. on 6ix.
Outlook Therapeutics, Inc. news
Read company news and market updates connected to Outlook Therapeutics, Inc..
Outlook Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Outlook Therapeutics, Inc..
Alternate listings
41O:GETTEX
DE · EUR
Alternate listing for Outlook Therapeutics, Inc.; the primary context on this page is OTLK:NASDAQ.
A4046T:LSX
DE · EUR
Alternate listing for Outlook Therapeutics, Inc.; the primary context on this page is OTLK:NASDAQ.
OTLK:BOATS
US · USD
Alternate listing for Outlook Therapeutics, Inc.; the primary context on this page is OTLK:NASDAQ.
A4046T:LS
DE · EUR
Alternate listing for Outlook Therapeutics, Inc.; the primary context on this page is OTLK:NASDAQ.
41O:TRADEGATE
DE · EUR
Alternate listing for Outlook Therapeutics, Inc.; the primary context on this page is OTLK:NASDAQ.
41O:FWB
DE · EUR
Alternate listing for Outlook Therapeutics, Inc.; the primary context on this page is OTLK:NASDAQ.
41O:DUS
DE · EUR
Alternate listing for Outlook Therapeutics, Inc.; the primary context on this page is OTLK:NASDAQ.
41O:HAM
DE · EUR
Alternate listing for Outlook Therapeutics, Inc.; the primary context on this page is OTLK:NASDAQ.
41O:MUN
DE · EUR
Alternate listing for Outlook Therapeutics, Inc.; the primary context on this page is OTLK:NASDAQ.
41O:SWB
DE · EUR
Alternate listing for Outlook Therapeutics, Inc.; the primary context on this page is OTLK:NASDAQ.